Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
Status:
TERMINATED
Trial end date:
2025-07-15
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, positive controlled, phase III trial to evaluate the safety and efficacy of ZX-7101A tablets versus oseltamivir phosphate suspension in children aged 5 years and \< 12 years with uncomplicated influenza.